Clinical Trial - Trial HKUCTR-2992
Access comprehensive clinical trial information for HKUCTR-2992 through Pure Global AI's free database. This Phase 1 trial is sponsored by GlaxoSmithKline Biologicals SA and is currently Not yet recruiting. The study focuses on Infection.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to HKU CLINICAL TRIALS REGISTRY data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
HKUCTR-2992
Phase 1
Not yet recruiting
Trial Details
HKU CLINICAL TRIALS REGISTRY • HKUCTR-2992
Untitled Trial
Ancillary study evaluating ChAd155-hIi-HBV shedding in a subset of chronic hepatitis B patients enrolled in the first-time-in-human, Phase I, randomised, multi-centric, single-blind study TH HBV VV-001.
Study Focus
Observational
Sponsor & Location
GlaxoSmithKline Biologicals SA
China
Timeline & Enrollment
Phase 1
N/A
Dec 31, 2021
ICD-10 Classifications
Bacterial infection, unspecified
Bacterial, viral and other infectious agents
Infection following immunization
Other infectious diseases
Viral infection, unspecified
Data Source
HKU CLINICAL TRIALS REGISTRY
HKUCTR-2992
Non-Device Trial